Glen Pyle: Association Between Premature Menopause and Coronary Heart Disease Risk
Glen Pyle, Professor, Member of Women’s Health Research Institute (WHRI) and of IMPART, shared a post on LinkedIn about a recent article by Priya M. Freaney et al. published in JAMA Cardiology:
“Menopause increases women’s cardiovascular disease risk and women who experience menopause before age 40 have an even higher risk.
A new study in JAMA Cardiology investigated the connection between premature menopause and coronary heart disease, and found Black women were threefold more likely than White women to enter menopause before age 40 (15.5% vs 4.8%).
The risk of coronary heart disease in these women was 40% higher than women who entered menopause after age 40, regardless of racial background.
Earlier studies have demonstrated a link between early (<45 years of age) and premature (<40 years of age) menopause with coronary heart disease within 7 years of menopause.
This study looked at a significantly longer window of risk (~30 years) and shows that the elevated risk persists.
While menopause is typically seen as a ‘reproductive’ issue best dealt with by gynecology professionals, this study by Priya M. Freaney and colleagues underscores the need for women, family physicians, and cardiologists to consider reproductive history in assessing cardiovascular disease risk.
Clear communication about patient history, risk factors, and strategies to mitigate cardiovascular risks are critical for ensuring a long and healthy life for women.”
Title: Premature Menopause and Lifetime Risk of Coronary Heart Disease
Authors: Priya M. Freaney, Hongyan Ning, Mercedes Carnethon, John T. Wilkins, Norrina B. Allen, Donald M. Lloyd-Jones, Sadiya S. Khan
Read the Full Article on JAMA Cardiology
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 14, 2026, 11:16Zahra Ghasemi: Breaking the Freezer Barrier in Plasma Transfusion
-
Sep 14, 2026, 09:44Mohammad Salar Amoli: Thrombin The Master Regulator of Coagulation
-
Sep 14, 2026, 09:23Claire Harrison: HemaSphere Introduces New Patient Editor Role
-
Sep 14, 2026, 09:13Eirini Zorba: Plasmapheresis in Focus Understanding Its Role in Patient Care
-
Sep 14, 2026, 08:55Abdulrahman Al-Mashdali։ Immune Checkpoint Inhibitor Associated HLH
-
Sep 14, 2026, 07:54Islam Sadek: SOHO2026 Highlights Advances in Hematologic Malignancies
-
Sep 14, 2026, 07:45Flora Peyvandi: Building a More Equitable Future for Hemophilia Care
-
Sep 14, 2026, 07:37Joseph Pierre Aboumsallem: ET Treatment Enters a New Chapter
-
Sep 14, 2026, 07:29Eric Topol: Will AI Replace Clinicians?